Symbol
| TSC22D3
| contributors: mct/npt/pgu - updated : 17-01-2014
|
HGNC name
| TSC22 domain family, member 3
|
HGNC id
| 3051
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
in synovial endothelial cells in rheumatoid arthritis | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
neuromuscular | myopathy | | |
absence of TSC22D3/L-GILZ in skeletal muscle tissue enhances muscle regeneration and glucocorticoids might be more effective in the symptomatic treatment of dystrophy | immunology | inflammatory | | |
Induction of GILZ expression in endothelial cells may represent a novel therapeutic modality with the potential to inhibit inflammatory leukocyte recruitment | reproduction | fertility | | |
possible target for novel therapies to intervene in male sterility |
| | | |
| Tsc22d3-2-deficient mice demonstrated a previously uncharacterized function of glucocorticoid-induced leucine zipper protein in testis development |